Subsidiary product Ganphosphatidylcholine of Tuoxin Pharmaceutical Group(301089.SZ) passed the US Self-GRAS certification.

Tuoxin Pharmaceutical Group (301089.SZ) announced that its wholly-owned subsidiary, Xinxing Jingquan Biotechnology Co., Ltd. (referred to as "Jingquan Biotechnology"), has successfully obtained Self-GRAS status for its product phosphatidylcholine based on the "Generally Recognized as Safe" (GRAS) guidelines of the U.S. Food and Drug Administration (FDA). The announcement shows that phosphatidylcholine is a choline compound that naturally exists in the human body and is also a key component of the cell membranes of brain nerve cells. As a highly bioavailable source of choline, its core benefits have been scientifically validated through extensive research, including: enhancing cognitive function, providing support for normal brain function to maintain brain health, improving performance and recovery after exercise, and playing a neuroprotective role to safeguard neurological health.